iBio, Inc. announced the appointment of Robert M. Lutz as its Chief Financial & Business Officer (“CFBO”), effective March 4, 2021. Mr. Lutz brings more than 25 years of experience to the Company, joining most recently from Strongbridge Biopharma plc. He served as CFO since August 2019, and prior to that, as Chief Business Officer since October 2014. As CFBO, Mr. Lutz will lead iBio’s finance organization and be responsible for building strong licensing capabilities and the financial planning & analysis function, as well as supporting iBio’s relationships with the investment community.